Tumor-Specific Protein Induced in Situ Self-Assembly of Peptide Drugs for Synergistic Mitochondria Disruption

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - (2024) vom: 27. Nov., Seite e2413069
1. Verfasser: Hao, Yi (VerfasserIn)
Weitere Verfasser: Hou, Da-Yong, Zhou, Lei, Fan, Yan-Lei, Wu, Xiu-Hai, Liu, Yi-Xuan, Xu, Yin-Sheng, Song, Ben-Li, Yi, Li, Qiao, Zeng-Ying, Wang, Hao, Xu, Shou-Ping
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article mitochondrial nanomaterials peptide self‐assembly synergy
LEADER 01000naa a22002652 4500
001 NLM380905892
003 DE-627
005 20241128232932.0
007 cr uuu---uuuuu
008 241128s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202413069  |2 doi 
028 5 2 |a pubmed24n1616.xml 
035 |a (DE-627)NLM380905892 
035 |a (NLM)39604290 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Hao, Yi  |e verfasserin  |4 aut 
245 1 0 |a Tumor-Specific Protein Induced in Situ Self-Assembly of Peptide Drugs for Synergistic Mitochondria Disruption 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 28.11.2024 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
520 |a © 2024 Wiley‐VCH GmbH. 
520 |a Mitochondria-targeted cancer therapy is an effective method for controlling tumor growth. However, the presence of repair mechanisms in tumor cells in response to mitochondrial damage poses significant challenges for treatment. By taking advantage of intracellular self-assembly technology, a peptide nanomaterial, RC-K-FX, that enters tumor cells in a monomeric form is designed. After binding to MUC1-C inside the cell membrane, RC-K-FX assembles into a spherical structure that stably encapsulates MUC1-C, inhibiting its dimerization and blocking the repair of stress-induced mitochondrial damage in tumor cells. Moreover, the self-assembled mitochondrial toxic peptide effectively destroys the mitochondria, and the loss of mitochondrial repair significantly increases tumor cytotoxicity by disrupting the redox balance, enhancing reactive oxygen species (ROS), inhibiting the nuclear factor (NF)-κB pathway, and suppressing the epithelial-mesenchymal transition (EMT) process. After intravenous administration, RC-G-FX accumulated at the tumor site, exhibiting improved anti-tumor effects and extending the overall survival of tumor-bearing mice. Therefore, the integration of the in situ self-assembly of peptide drugs and damage to mitochondrial repair mechanisms provides effective therapeutic options for malignancy 
650 4 |a Journal Article 
650 4 |a mitochondrial 
650 4 |a nanomaterials 
650 4 |a peptide 
650 4 |a self‐assembly 
650 4 |a synergy 
700 1 |a Hou, Da-Yong  |e verfasserin  |4 aut 
700 1 |a Zhou, Lei  |e verfasserin  |4 aut 
700 1 |a Fan, Yan-Lei  |e verfasserin  |4 aut 
700 1 |a Wu, Xiu-Hai  |e verfasserin  |4 aut 
700 1 |a Liu, Yi-Xuan  |e verfasserin  |4 aut 
700 1 |a Xu, Yin-Sheng  |e verfasserin  |4 aut 
700 1 |a Song, Ben-Li  |e verfasserin  |4 aut 
700 1 |a Yi, Li  |e verfasserin  |4 aut 
700 1 |a Qiao, Zeng-Ying  |e verfasserin  |4 aut 
700 1 |a Wang, Hao  |e verfasserin  |4 aut 
700 1 |a Xu, Shou-Ping  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g (2024) vom: 27. Nov., Seite e2413069  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g year:2024  |g day:27  |g month:11  |g pages:e2413069 
856 4 0 |u http://dx.doi.org/10.1002/adma.202413069  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |j 2024  |b 27  |c 11  |h e2413069